ClinicalTrials.Veeva

Menu

Liver Ischemia-reperfusion Injury and Clinical Data Analysis

Q

Qin Zhang

Status

Enrolling

Conditions

Liver Injury

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT06080308
TJ-IRB20230940

Details and patient eligibility

About

Searching for new targets for the diagnosis and treatment of liver ischemia-reperfusion injury.

Full description

Through the analysis of serological data during liver resection elective surgery with hepatic pedicle occlusion and reperfusion, as well as the analysis of patient-related data, we aim to identify key target points that affect reperfusion injury and explore their underlying mechanisms.

Enrollment

270 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Willingness to participate in the study and has signed an informed consent form. 2) Age ≥ 18 years and ≤ 70 years. 3) ASA classification ≤ III. 4) Criteria for liver ischemia-reperfusion injury patients: patients undergoing elective liver resection surgery with hepatic pedicle occlusion and reperfusion during the procedure.

Exclusion criteria

  1. Patients with adverse events during surgery. 2) Patients in the end stage of disease with liver failure. 3) Liver tumor metastasis with concomitant severe heart failure or chronic renal insufficiency, etc. 4) Deemed unsuitable for participation in the study based on the judgment of the researchers.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems